Table 1.
Demographic metrics displayed by participant group.
Demographic | Control | Schizophrenia | Bipolar | |||
---|---|---|---|---|---|---|
Sex | n | n | n | |||
Female | 25 | 24 | 11 | |||
Male | 19 | 39 | 12 | |||
Total | 44 | 63 | 23 | |||
Age (Mean ± SD) | 38.8 ± 12.8 | 40.8 ± 13.2 | 40.9 ± 13.5 | |||
Race** | n | n | n | |||
Caucasian, non-Hispanic | 12 | 4 | 4 | |||
Black, non-Hispanic | 18 | 49 | 16 | |||
Asian or other Pacific Islander | 10 | 2 | 0 | |||
Hispanic | 4 | 8 | 3 | |||
BMI (Mean ± SD)* | 29.3 ± 8.1 | 32.8 ± 8.6 | 28.8 ± 7.7 | |||
Nicotine* | Yes | No | Yes | No | Yes | No |
7 | 35 | 27 | 35 | 10 | 13 | |
Medication | Yes | No | Yes | No | Yes | No |
Typical Antipsychotics | 0 | 44 | 10 | 53 | 1 | 22 |
Atypical Antipsychotics | 0 | 44 | 50 | 10 | 16 | 7 |
mRNA Expression (Mean ± SD) | n | n | n | |||
C4A | 3.94 ± 1.55 | 4.14 ± 1.52 | 3.66 ± 1.20 | |||
STAT1 | 6.38 ± 5.02 | 5.31 ± 4.01 | 4.89 ± 3.23 | |||
IRF-1* | 10.87 ± 5.65 | 8.50 ± 4.48 | 7.69 ± 3.05 |
p ≤ .05.
p ≤ .01.n.s.=non-significant